Tilray Inc (NASDAQ:TLRY - Get Free Report) shares rose 1.6% during mid-day trading on Thursday . The company traded as high as $0.45 and last traded at $0.44. Approximately 7,438,187 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 28,131,183 shares. The stock had previously closed at $0.43.
Wall Street Analysts Forecast Growth
TLRY has been the topic of a number of analyst reports. Piper Sandler lowered their target price on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 9th. Roth Capital restated a "neutral" rating on shares of Tilray in a report on Monday, April 14th.
Get Our Latest Report on Tilray
Tilray Stock Down 1.0%
The company has a market cap of $445.27 million, a PE ratio of -1.47 and a beta of 1.95. The business's fifty day simple moving average is $0.52 and its two-hundred day simple moving average is $0.91. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The business had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. On average, analysts predict that Tilray Inc will post -0.2 earnings per share for the current year.
Institutional Investors Weigh In On Tilray
A number of hedge funds have recently bought and sold shares of the stock. Lido Advisors LLC purchased a new stake in Tilray in the 4th quarter valued at $28,000. Verdence Capital Advisors LLC acquired a new position in Tilray during the fourth quarter worth $29,000. Dudley Capital Management LLC acquired a new position in shares of Tilray during the 4th quarter worth $29,000. Cerity Partners LLC purchased a new stake in Tilray during the first quarter worth about $31,000. Finally, Capital Management Associates Inc grew its holdings in shares of Tilray by 100.0% in the 1st quarter. Capital Management Associates Inc now owns 50,760 shares of the company's stock worth $33,000 after acquiring an additional 25,380 shares during the period. Institutional investors and hedge funds own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
